DANIELLE O'DELL: Open Payments
NPI 1134613425 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Medtronic, Inc. | 1 | $25 |
| Seqirus USA Inc | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Auvelity, CAPLYTA, INVEGA SUSTENNA, Kerendia, MINIMED 780G, Fluad, GARDASIL 9, REXULTI.
Industry payments across KY — which companies pay providers there.
